Skip to main content
. 2024 Sep 25;25(19):10304. doi: 10.3390/ijms251910304

Table 3.

Features selected based on ML models trained on targeted proteomics.

Model Features Selected
Urine Models predicting PHVD
Urine IVH DEFB4A; GA at birth
Urine IVHp GA at birth; TDGF1
Urine PHVD a
Urine IVH_IVHp RBKS; GA at birth; PPP3R1
Urine IVH_IVHp_PHVD RBKS; GA at birth; CD33; SNCG; PP3R1
Serum Models predicting PHVD
Blood IVH PPP3R1; GA at birth
Blood IVHp FUT8; GA at birth; RBKS
Blood PHVD KLB; GA at birth; PAEP; PTS; AOC1; ISLR2; NXPH1; IVHgrade_MAX; VSTMT
Blood IVH_IVHp GA at birth; PPP3R1; FUT8
Blood IVH_IVHp_PHVD DPEP2; GA at birth
Urine Models predicting survival
Urine IVH GA at birth; HSP90B1; KIRREL2
Urine IVHp a
Urine PHVD FGFR2; GA at birth
Urine IVH_IVHp GA at birth
Urine IVH_IVHp_PHVD a
Urine PHVDp1 a
Urine PHVDp2 a
Urine PHVDp3 a
Urine 28 days of life a
Urine 32 weeks a
Urine term-equivalent age Not able to perform ML
Serum Models predicting survival
Blood IVH PRTFDC2; GA at birth; AKT1S1; FKBP5; SNCG; DPEP2
Blood IVHp FGFR2; GA at birth; IL15; FKBP5; DPEP2; CLSTN1; IFNL1; RBKS
Blood PHVD GPNMB; DSG3; FGFR2; NEFL; IL15; CDH15; ADAM15; GA at birth; KIR2DL3; PLA2G10
Blood IVH_IVHp DPEP2; GA at birth; IL15; GSTP1; COL4A3BP; PRTFDC1; SNCG
Blood IVH_IVHp_PHVD GA at birth; DSG3
Blood PHVDp1 FGFR2; ADAM15; NEFL; PLA2G10; IL15; CDH15; BST2; FCAR; GA at birth
Blood PHVDp2 GA at birth; TNFRSE13C; PAEP
Blood PHVDp3 IFNL1; SNCG; GA at birth; TDGF1; ADGRB3; IL32
Blood 28 days of life a
Blood 32 weeks a
Blood term-equivalent age a
Applied thresholds for the models: AUC-ROC ≥ 0.7; Sensitivity ≥ 0.6 and Selectivity ≥ 0.6.Features selected from models passing thresholds had to display a relative variable importance measure ≥ 50.

a Indicates, that no model passed the threshold for evaluation. Abbreviations: GA, gestational age; IVH, interventricular hemorrhage; PHVD, posthemorrhagic ventricular dilatation; IVHgrade_MAX, maximum degree of IVH.